Events & News

Events

Events

The Use of Virtual Controls in Preclinical Research: Promise and Predicament

Join BioCelerate for its second meeting of the BioCelerate Preclinical Collaboration Forum, which brings together cross-industry stakeholders to advance conversation and innovation in preclinical research.

Learn More

Leveraging CDISC SEND Data Sets for Study Analyses

Learn More

News

News

Janice Chang Named New CEO of TransCelerate and BioCelerate

Learn More

BioCelerate Newsletter – November 2021

Learn More

Harmonization of SEND Implementation to Enable Historical Control Data Analysis, the Recommendations for Populating Control Type (TCNTRL) with CDISC SEND Controlled Terminology White Paper was published on the PHUSE website

Learn More

BioCelerate Continues to Help Improve Nonclinical Study Operations through Public Private Partnership with the FDA

Learn More

BioCelerate Newsletter – April 2021

Learn More

SEND Implementation for Cross-Study Analysis Initiative Publishes New Manuscript: Leveraging the Value of CDISC SEND Datasets for Cross-Study Analysis: Incidence of Microscopic Findings in Control Animals

Learn More

BioCelerate Newsletter – November 2020

Learn More

BioCelerate Newsletter – March 2020

Learn More

BioCelerate Featured in Applied Clinical Trials

Learn More

BioCelerate Releases V1.1 of the Nonclinical Protocol Template for Repeat-Dose Toxicology Studies

Learn More

BioCelerate Newsletter – November 2019

Learn More

BioCelerate Launches Two New Initiatives and Expands Membership

Learn More

BioCelerate Newsletter – April 2019

Learn More

TransCelerate and BioCelerate Launch New Technology Platform to Enable R&D Data Sharing

Learn More

TransCelerate BioPharma Introduces New Subsidiary BioCelerate to Increase Efficiencies in Preclinical Research

Learn More